Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury
NCT07738328Phase 2Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Terbinafine in acute kidney injury (AKI), sponsored by Guangdong Provincial People's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Terbinafine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07738328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738328.